Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$370M Buy
13,178,661
+14,511
+0.1% +$386K 0.1% 163
2025
Q4
$328M Sell
13,164,150
-676,931
-5% -$17.1M 0.09% 184
2025
Q3
$353M Sell
13,841,081
-1,339,546
-9% -$33.1M 0.09% 180
2025
Q2
$368M Sell
15,180,627
-204,573
-1% -$4.77M 0.1% 170
2025
Q1
$390M Buy
15,385,200
+226,234
+1% +$5.92M 0.12% 159
2024
Q4
$402M Sell
15,158,966
-621,603
-4% -$16.9M 0.11% 151
2024
Q3
$457M Sell
15,780,569
-2,659,550
-14% -$77.6M 0.13% 140
2024
Q2
$516M Buy
18,440,119
+876,259
+5% +$24.1M 0.15% 119
2024
Q1
$487M Sell
17,563,860
-305,927
-2% -$8.49M 0.14% 127
2023
Q4
$514M Buy
17,869,787
+1,272,415
+8% +$38.5M 0.17% 116
2023
Q3
$551M Sell
16,597,372
-2,041,936
-11% -$72.2M 0.19% 108
2023
Q2
$684M Sell
18,639,308
-261,776
-1% -$10.2M 0.24% 91
2023
Q1
$771M Sell
18,901,084
-521,412
-3% -$22.5M 0.29% 82
2022
Q4
$995M Sell
19,422,496
-464,981
-2% -$22.3M 0.39% 58
2022
Q3
$870M Sell
19,887,477
-742,023
-4% -$36.1M 0.35% 63
2022
Q2
$1.08B Buy
20,629,500
+13,528
+0.1% +$689K 0.42% 50
2022
Q1
$1.12B Sell
20,615,972
-7,470,695
-27% -$388M 0.36% 54
2021
Q4
$1.66B Buy
28,086,667
+4,177,367
+17% +$207M 0.49% 36
2021
Q3
$1.03B Sell
23,909,300
-630,258
-3% -$27.9M 0.32% 62
2021
Q2
$961M Sell
24,539,558
-301,412
-1% -$11.7M 0.29% 74
2021
Q1
$900M Sell
24,840,970
-5,790,407
-19% -$206M 0.29% 71
2020
Q4
$1.13B Sell
30,631,377
-1,691,092
-5% -$62M 0.38% 46
2020
Q3
$1.13B Sell
32,322,469
-1,294,494
-4% -$45.4M 0.43% 48
2020
Q2
$1.04B Sell
33,616,963
-9,337,149
-22% -$317M 0.42% 47
2020
Q1
$1.33B Buy
42,954,112
+10,144,496
+31% +$346M 0.65% 26
2019
Q4
$1.22B Buy
32,809,616
+189,123
+0.6% +$6.74M 0.46% 41
2019
Q3
$1.11B Sell
32,620,493
-5,414,419
-14% -$197M 0.45% 40
2019
Q2
$1.56B Buy
38,034,912
+36,409,822
+2,240% +$1.45B 0.62% 28
2019
Q1
$65.5M Sell
1,625,090
-326,875
-17% -$13.1M 0.35% 52
2018
Q4
$80.8M Sell
1,951,965
-241,899
-11% -$10M 0.51% 30
2018
Q3
$91.7M Sell
2,193,864
-9,722
-0.4% -$374K 0.49% 33
2018
Q2
$75.8M Sell
2,203,586
-6,411
-0.3% -$219K 0.48% 37
2018
Q1
$74.4M Buy
2,209,997
+293,450
+15% +$10.1M 0.49% 38
2017
Q4
$65.9M Buy
1,916,547
+128,028
+7% +$4.37M 0.42% 46
2017
Q3
$60.6M Buy
1,788,519
+181,586
+11% +$5.84M 0.4% 49
2017
Q2
$51.2M Sell
1,606,933
-380,938
-19% -$12M 0.33% 63
2017
Q1
$64.5M Sell
1,987,871
-570,230
-22% -$18M 0.38% 52
2016
Q4
$78.8M Buy
2,558,101
+145,214
+6% +$4.43M 0.4% 49
2016
Q3
$77.5M Sell
2,412,887
-45,457
-2% -$1.52M 0.45% 46
2016
Q2
$82.1M Sell
2,458,344
-138,297
-5% -$4.41M 0.5% 41
2016
Q1
$73K Sell
2,596,641
-876,445
-25% -$25M 0.38% 42
2015
Q4
$106K Sell
3,473,086
-313,144
-8% -$9.85M 0.55% 21
2015
Q3
$113K Sell
3,786,230
-59,468
-2% -$1.91M 0.64% 19
2015
Q2
$122K Sell
3,845,698
-25,995
-0.7% -$847K 0.66% 17
2015
Q1
$128M Buy
3,871,693
+494,672
+15% +$15.7M 0.7% 15
2014
Q4
$99.8M Sell
3,377,021
-217,362
-6% -$6.23M 0.56% 25
2014
Q3
$101M Buy
3,594,383
+27,139
+0.8% +$762K 0.62% 18
2014
Q2
$100M Sell
3,567,244
-122,306
-3% -$3.49M 0.61% 21
2014
Q1
$112M Sell
3,689,550
-354,730
-9% -$10.6M 0.67% 15
2013
Q4
$118M Sell
4,044,280
-58,446
-1% -$1.7M 0.76% 12
2013
Q3
$112M Sell
4,102,726
-621,757
-13% -$16.9M 0.72% 12
2013
Q2
$126M Buy
+4,724,483
New +$131M 0.84% 10

Other funds holding PFE

Nuveen's PFE Position: Q1 2026 in Review

Nuveen increased its Pfizer (PFE) stake by 0.11% in Q1 2026, buying an estimated $386K and bringing the position to 13,178,661 shares worth $370M. The position accounts for 0.1% of the portfolio, ranked #163.

Nuveen first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.66B in Q4 2021. 2,943 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Nuveen held 13,178,661 shares of Pfizer worth $370M as of Q1 2026.
  • Nuveen bought 14,511 Pfizer shares in Q1 2026, an estimated $386K.
  • Pfizer made up 0.1% of Nuveen's portfolio in Q1 2026, its #163 holding.
  • Nuveen first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Pfizer position peaked at $1.66B in Q4 2021.
  • 2,943 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.